Sigurdur Oli Olafsson joins Watson
This article was originally published in Scrip
Executive Summary
Sigurdur Oli Olafsson has joined Watson Pharmaceuticals as executive vice-president of global generics, effective 1 September. He will have responsibility for global generics sales and marketing, with an emphasis on leading the company's expansion in global markets. Mr Olafsson, who most recently served as chief executive officer of the Actavis Group, succeeds Thomas Russillo, who will retire at the end of this year.